Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

Peripheral Blood-Derived Mesenchymal Stem Cells Promote A2 Phenotype Polarization in Astrocytes via TGF-β-Mediated PI3K/Akt Pathway Activation

Yang RL., Zhao DZ., Wei HX., Chen SY., Yang YB., Yang K.

Prospective Study on Spinal Cord Injury, Neuroinflammation, published in Eur J Med Res (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Eur J Med Res (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40605103
PMCID
PMC12220059
DOI
10.1186/s40001-025-02814-x
Citations
1

Abstract (original English)

In the pathogenesis of spinal cord injury (SCI), excessive and persistent neuroinflammation plays a crucial role in the development of the condition. Despite significant advances in modern medicine, there remains a lack of definitive treatments that can fully restore neurological function in patients with SCI. Research has demonstrated that A2-reactive astrocytes are beneficial for the recovery of neurological function following SCI. Therefore, we utilized Transwell co-culture of peripheral blood-derived mesenchymal stem cells (PB-MSCs) with astrocytes (AS) to explore the potential mechanism by which PB-MSCs polarize AS to the A2 phenotype through the TGF-β/PI3K/Akt signaling pathway. In this study, ELISA analysis revealed that PB-MSCs and their conditioned medium (P-CM) significantly induced the expression of IL-10, IL-13, and TGF-β in AS. The addition of LY294002 and AF-101 reversed this effect. Furthermore, western blotting and immunofluorescence assays demonstrated that p-Akt signaling was significantly upregulated in AS co-cultured with PB-MSCs or P-CM, accompanied by an increase in the A2-reactive phenotype marker S100A10. This effect could also be reversed by inhibiting the PI3K/Akt pathway with LY294002 and AF-101. In conclusion, PB-MSCs can mediate the polarization of AS toward the A2 phenotype by activating the PI3K/Akt pathway.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
AstrocytesCells, CulturedMesenchymal Stem CellsAnimalsHumansRatsSpinal Cord InjuriesTransforming Growth Factor betaCoculture TechniquesSignal Transduction

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research